Home

Martine A. Rothblatt, Chairperson & CEO: United Therapeutics UTHR Sell · Filed 04/16

Trade details

Type
Insider sale
Amount
$2,133,521.25
Shares · price
3,675 sh · $580.55 a share
Held after
41,470 sh
Trade date
26/04/14
Filed
26/04/16
Days to filing
2 days

Sold 8.1% of holdings

Share of holding sold
8.1%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 03/15~05/14

Martine A. Rothblatt's recent trades

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1.1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $1M

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $664.2K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $574.9K

    Filed 09/30

  • Martine A. Rothblatt

    Sell10b5-1 planUnited Therapeutics

    $262.3K

    Filed 09/30

Martine A. Rothblatt, Chairman — sold $2.1M of United Therapeutics UTHR · 8.1% of holdings · 10b5-1 plan | Whalegun